ACE inhibitors vs ARBs: cough, potassium and nursing priorities

Use the mechanism to understand the difference in cough

Lisinopril is an ACE inhibitor; losartan is an angiotensin II receptor blocker, or ARB. ACE inhibition also interferes with bradykinin breakdown, helping explain the characteristic dry cough. An ARB acts at the receptor instead. This is a useful mechanism-to-finding connection, but a cough in a person taking lisinopril still requires assessment for other possible causes.

For hypertension, guidance supports considering an ARB when an ACE inhibitor is not tolerated because of cough. This is a prescribing decision after evaluation, not a nursing instruction to exchange tablets independently. In a comparison question, distinguish the expected alternative from an immediate safety action. The correct response depends on whether the stem describes an inconvenient symptom or acute deterioration.

Separate a dry cough from a threatened airway

A persistent cough without airway compromise and new tongue swelling carry different priorities. ACE inhibitor-associated angioedema can involve the lips, tongue or larynx and can arise during treatment even after earlier doses were tolerated. Swelling with voice change or breathing difficulty requires immediate escalation and airway assessment. Follow the emergency pathway and do not administer further suspected offending medicine.

ARBs do not guarantee freedom from angioedema: it has also been reported with losartan. A history of ACE inhibitor angioedema needs careful prescriber review rather than automatic substitution based on the cough rule. For study purposes, keep the two histories separate. Intolerance from cough and a previous potentially dangerous swelling reaction are not interchangeable entries in a medication history.

Monitor the shared effects on pressure, potassium and kidneys

Obtain the required baseline blood pressure, potassium and renal function information, then follow the repeat-testing plan after initiation or changes. Both groups can produce hypotension, increased potassium or clinically important deterioration in renal function. Dizziness should prompt assessment of blood pressure and symptoms rather than being dismissed because it appears on a list of familiar adverse effects.

A modest creatinine change may be expected, while a larger or progressive change can require investigation and treatment adjustment. Interpret the trend with hydration, concurrent medicines and the underlying indication. Guidance uses different action thresholds in different settings, so an exam shortcut such as stop for any increase is unreliable. In clinical care, apply the prescribed local monitoring pathway.

Check pregnancy precautions and medicines taken together

Lisinopril and losartan carry fetal toxicity warnings. New pregnancy information needs prompt prescriber contact and a replacement treatment plan; changing an ACE inhibitor to an ARB does not remove that concern. Ask about pregnancy plans when relevant to the care setting. The comparison should help candidates recognise a shared precaution rather than memorise it for only one class.

Potassium supplements, potassium-containing salt substitutes and other potassium-raising medicines need review. NSAIDs can also complicate renal safety. Combining an ACE inhibitor with an ARB is not recommended for routine hypertension treatment because blocking the same system at two points increases adverse-effect risk. Medication reconciliation therefore includes nonprescription products and duplicate class therapy, as well as checking the main prescription label.

Reason through a hypothetical lisinopril-to-losartan question

Consider an original study scenario: an adult taking lisinopril reports an irritating dry cough, has stable observations and denies facial swelling or breathing difficulty. The options are to discuss a possible ARB with the prescriber, add an ARB to lisinopril, or ignore the symptom permanently. Discussion of an alternative is strongest; duplicate therapy does not solve the underlying tolerability problem.

Change the scenario to a swollen tongue and hoarse voice. Choosing another long-term antihypertensive is now secondary to emergency airway assessment and escalation. If losartan is subsequently prescribed, the patient still needs the ordered potassium, renal and blood pressure follow-up. Practise stating the feature that changed your answer; this checks whether your reasoning follows the patient rather than a drug-name association.

Sources and further reading

DailyMed: Lisinopril prescribing information. ACE inhibition, cough, angioedema and fetal toxicity.

DailyMed: Losartan prescribing information. Receptor blockade, potassium and renal risks, interactions, angioedema reports and fetal toxicity.

NICE: Hypertension in adults recommendations. ARB consideration for ACE inhibitor cough and avoidance of combined ACE inhibitor and ARB therapy.

NHS Specialist Pharmacy Service: ACE inhibitor and ARB monitoring. Baseline and follow-up blood pressure, electrolyte and renal monitoring with contextual interpretation.